Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer

Journal of Surgical Oncology

Volumn 100, Issue 3, 2009, Pages 248-251

  Bharat, Ankit ^a   Aft, Rebecca L ^a,b   Gao, Feng ^c   Margenthaler, Julie A ^a  

^a WUSM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Mortality; Young age ( 40 years)

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; AGE; BREAST TUMOR; GENETICS; MIDDLE AGED; MORTALITY; NEGRO; PATHOLOGY; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; STATISTICS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 70249123138     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21268     Document Type: Article

References (15)

1. Smigal C, Jemal A,Ward E, et al.: Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin 2006;56:168-183. (Pubitemid 43847927)
2. Bland KI, Menck HR, Scott-Conner CE, et al.: The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-1273.
3. Chung M, Chang HR, Bland KI, et al.: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77:97-103. (Pubitemid 26002742)
4. Elkhuizen PH, van de Vijver MJ, Hermans J, et al.: Local recurrence after breast-conserving therapy for invasive breast cancer: High incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998;40:859-867. (Pubitemid 28150804)
5. Thuerlimann B: International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland. Breast Cancer 2001;8:294-297.
6. Goldstein NS, Kestin L, Vicini F: Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol 2003;120:500-527. (Pubitemid 37186045)
7. Kurtz JM, Jacquemier J, Amalric R, et al.: Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990;65:1867-1878. (Pubitemid 20116664)
8. Winchester DP, Osteen RT, Menck HR: The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996;78:1838-1843.
9. Adami HO, Malker B, Holmberg L, et al.: The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986;315:559-563. (Pubitemid 16052469)
10. Gnerlich J, Deshpande AD, Jeffe DB, et al.: Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. JACS in press.
11. Sorlie T, Perou CM, Tibshirani R, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-10873. (Pubitemid 32878711)
12. Sotiriou C, Neo SY, McShane LM, et al.: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003;100:10393-10399. (Pubitemid 37071889)
13. Carey LA, Perou CM, Livasy CA, et al.: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-2501.
14. Colleoni M, Rotmensz N, Peruzzotti G, et al.: Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 2006;17:1497-1503. (Pubitemid 44542034)
15. Ahn SH, Son BH, Kim SW, et al.: Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea - A report from the Korean Breast Cancer Society. J Clin Oncol 2007;25:2360-2368.